Sionna Therapeutics, Inc. - Common Stock
Sionna Therapeutics, Inc. - Common Stock
Share · US8294011080 · SION (XNAS)
Overview
Analyst Grade Summary
gauge-img
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
0
1
0
No Price
19.12.2025 22:18
Current Prices from Sionna Therapeutics, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
SION
USD
19.12.2025 22:18
42,35 USD
-1,79 USD
-4,06 %
Share Float & Liquidity
Free Float 55,33 %
Shares Float 24,69 M
Shares Outstanding 44,63 M
Company Profile for Sionna Therapeutics, Inc. - Common Stock Share
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
AI Analysis of Sionna Therapeutics, Inc. - Common Stock
Click any analysis below to get instant AI insights from finAgent

Company Data

Name Sionna Therapeutics, Inc. - Common Stock
Company Sionna Therapeutics, Inc.
Symbol SION
Website https://www.sionnatx.com
Primary Exchange XNAS NASDAQ
ISIN US8294011080
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Michael Cloonan
Market Capitalization 2 Mrd.
Country United States of America
Currency USD
Employees 0,0 T
Address 21 Hickory Drive Suite 500, 02451 Waltham
IPO Date 2025-02-07

Ticker Symbols

Name Symbol
NASDAQ SION
More Shares
Investors who hold Sionna Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:
Millionaire Property Fund
Millionaire Property Fund Share
SPDR MSCI EMU UCITS ETF
SPDR MSCI EMU UCITS ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025